Blog

Contrasting Organovo (ONVO) & Editas Medicine (EDIT) – TrueBlueTribune


Frisco Fastball

Contrasting Organovo (ONVO) & Editas Medicine (EDIT)
TrueBlueTribune
It is developing a genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR) technology. CRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either CRISPR associated protein 9
Zacks Investment Research: Stock Research, Analysis, & RecommendationsZacks.com


SEC FORM 4 – SEC.govSEC.gov
SEC FORM 4 – SEC.govSEC.gov

all 77 news articles »

2017-12-27 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.